These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5742417)

  • 41. Reported mutations in GIGYF2 are not a common cause of Parkinson's disease.
    Vilariño-Güell C; Ross OA; Soto AI; Farrer MJ; Haugarvoll K; Aasly JO; Uitti RJ; Wszolek ZK
    Mov Disord; 2009 Mar; 24(4):619-20. PubMed ID: 19133664
    [No Abstract]   [Full Text] [Related]  

  • 42. Parkinson's disease after open-heart surgery.
    Hägglund JV; Aquilonius SM
    Mov Disord; 1996 Jul; 11(4):451-2. PubMed ID: 8813231
    [No Abstract]   [Full Text] [Related]  

  • 43. [Prevalence of Parkinson disease in an urban area of the Ciudad de La Habana province, Cuba. Door-to-door population study].
    Giroud Benítez JL; Collado-Mesa F; Esteban EM
    Neurologia; 2000; 15(7):269-73. PubMed ID: 11075574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Study of Parkinson's disease-causing mechanism and development of anti-Parkinson's disease drugs using endogenous substances in brain].
    Ohta S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Feb; 25(1):39-42. PubMed ID: 15796069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A retrospective study of cranial strain patterns in patients with idiopathic Parkinson's disease.
    Rivera-Martinez S; Wells MR; Capobianco JD
    J Am Osteopath Assoc; 2002 Aug; 102(8):417-22. PubMed ID: 12201545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MEP latency shift after implantation of deep brain stimulation systems in the subthalamic nucleus in patients with advanced Parkinson's disease.
    Hidding U; Bäumer T; Siebner HR; Demiralay C; Buhmann C; Weyh T; Moll C; Hamel W; Münchau A
    Mov Disord; 2006 Sep; 21(9):1471-6. PubMed ID: 16703590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monograph series on aging-related diseases: XII. Parkinson's disease--recent developments and new directions.
    Kontakos N; Stokes J
    Chronic Dis Can; 1999; 20(2):58-76. PubMed ID: 10455038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Relationship between weight loss and dysphagia in patients with Parkinson's disease].
    Nozaki S; Saito T; Matsumura T; Miyai I; Kang J
    Rinsho Shinkeigaku; 1999 Oct; 39(10):1010-4. PubMed ID: 10655760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen.
    Ascherio A; Weisskopf MG; O'Reilly EJ; McCullough ML; Calle EE; Rodriguez C; Thun MJ
    Am J Epidemiol; 2004 Nov; 160(10):977-84. PubMed ID: 15522854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parkinson's disease and related syndromes.
    Weiner WJ
    Med Sect Proc; 1993; ():195-203. PubMed ID: 8078870
    [No Abstract]   [Full Text] [Related]  

  • 51. [Transmission of a neurologic degeneration in a family for 4 generations manifested under variable semiologic aspects (pure pyramidal, pure cerebello-pyramidal involvement or involvement with abolition of reflexes and severe sensory disorders].
    Mettey R; Hoppeler A; Gil R
    J Genet Hum; 1981 Sep; 29(3):227-34. PubMed ID: 7334346
    [No Abstract]   [Full Text] [Related]  

  • 52. Assessment of cortico-spinal tract impairment in multiple system atrophy using transcranial magnetic stimulation.
    Eusebio A; Azulay JP; Witjas T; Rico A; Attarian S
    Clin Neurophysiol; 2007 Apr; 118(4):815-23. PubMed ID: 17317305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urinary incontinence and minimal pyramidal disease.
    Thomas DG; Davies-Jones GA; Clarke SJ
    Br J Urol; 1980 Dec; 52(6):460-2. PubMed ID: 7459572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Parkinson's syndrome caused by meningioma of the sphenoid ala].
    La Torre E; Forni C
    Riv Neurobiol; 1968; 14(4):519-30. PubMed ID: 5738405
    [No Abstract]   [Full Text] [Related]  

  • 55. [Physiopathologic systematization of pyramidal syndrome].
    Barraquer Bordas L
    Neurologia; 1986; 1(6):250-6. PubMed ID: 3078967
    [No Abstract]   [Full Text] [Related]  

  • 56. [Medullary liberation and its significance].
    MECCHERI LA
    Sem Med; 1958 Jun; 112(25):1083-7 passim. PubMed ID: 13580386
    [No Abstract]   [Full Text] [Related]  

  • 57. Pyramidal tract signs and Parkinson's disease.
    Fénelon G; Guillard A
    Lancet; 1992 Apr; 339(8799):1001. PubMed ID: 1348793
    [No Abstract]   [Full Text] [Related]  

  • 58. [Modification of Babinski's phenomenon].
    van Thanh L
    Cesk Neurol; 1973 Nov; 36(6):399-2. PubMed ID: 4755314
    [No Abstract]   [Full Text] [Related]  

  • 59. [Complex syndrome composed from myelopathic and myopathic signs and from degeneration of the pyramidal tract].
    BARRAQUER FERRE L; CASTANER VENDRELL E
    Clin Lab (Zaragoza); 1952 Oct; 54(319):288-90. PubMed ID: 13033100
    [No Abstract]   [Full Text] [Related]  

  • 60. [Subdural hematoma of the hemisphere with homolateral pyramidal syndrome: clinical contribution].
    ARDITO R
    Riv Sper Freniatr Med Leg Alien Ment; 1954 Mar; 78(1):123-54. PubMed ID: 13186732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.